Methods for improving the quality of life of a patient with a peanut allergy
AssigneeSociete des Produits Nestle S.A.
InventorChristine Birchwood
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods of improving the quality of life of a subject having a peanut allergy. In certain embodiments, the disclosure provides methods for improving the quality of life of a subject having a peanut allergy by administering a peanut composition according to an oral immunotherapy schedule. In certain embodiments, the disclosure provides methods for improving the quality of life of a subject having a peanut allergy by informing the subject they are to be, or are being, administered a peanut composition according to an oral immunotherapy schedule.
Claims33
A method of improving the quality of life of a patient with a peanut allergy, comprising:
- administering to the patient a peanut composition according to an oral immunotherapy schedule comprising an up-dosing phase and a maintenance phase;
- wherein the peanut composition is administered to the patient during the maintenance phase of the oral immunotherapy schedule at a dose of about 300 mg peanut protein.
A method of improving the quality of life of a patient with a peanut allergy, as assessed by a quality of life questionnaire (QoLQ), the method comprising administering to the patient a peanut composition according to an oral immunotherapy schedule comprising an up-dosing phase and a maintenance phase;
- wherein the peanut composition is administered to the patient during the maintenance phase of the oral immunotherapy schedule at a dose of about 300 mg peanut protein.
Dependencies are inferred from the claim text.